THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation

Yuxi Ding; Xiaoling Liu; Yue Yuan; Yunjian Sheng; Decheng Li; Suvash Chandra Ojha; Changfeng Sun; Cunliang Deng

doi:doi:10.18632/aging.203900

← Back

Research Paper Volume 14, Issue 4 pp 1743—1766

THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation

Figure 4. Overall survival (OS) Kaplan-Meier curves of the 12 hub genes in HCC patients. (A) AFP, p = 0.780. (B) IGF1, p = 0.008. (C) BCHE, p = 0.108. (D) ACSM3, p = 0.003. (E) LCAT, p <0.001. (F) ACSL4, p = 0.709. (G) ACADS, p = 0.045. (H) ENO3, p = 0.156. (I) CYP1A2, p = 0.353. (J) THRSP, p = 0.013. (K) GSTZ1, p = 0.089. (L) SRD5A2, p = 0.016.